State Stem Cell Agency ICOC Agenda 08-08-07

Aug 8, 2007
Main Location: 

Mission Bay Conference Center at UCSF
Robertson Auditorium
1675 Owens St.
San Francisco, CA 94158

California State Stem Cell Agency

 

REGULAR MEETING OF THE ICOC to the CIRM

THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE ("ICOC")
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 
Date: Wednesday, August 8, 2007

Time:  9:30 AM-5:00 PM (Estimated)

Location:

  • Mission Bay Conference Center at UCSF
    Robertson Auditorium
    1675 Owens St.
    San Francisco, CA 94158
 

OPEN SESSION

  1. Call to Order.
  2. Pledge of Allegiance.
  3. Roll Call.

    [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

 

CONSENT ITEMS

    4. Consideration of minutes from the following ICOC meetings:
           a. April 10, 2007
           b. May 2, 2007
           c. June 4-5, 2007.
    5. Consideration of regulation 100120: Medical and Ethical Standards, Record Keeping Regulation.
    6. Amendments to the CIRM Conflict of Interest Code. Approval will allow staff to initiate the regulatory amendment  process with the OAL and the Fair Political Practices Commission, our code reviewing body.
 

EXECUTIVE PRESENTATIONS

  1. Chairman's Report.
  2. Reports from Acting President & Interim Chief Scientific Officer.
 

ACTION ITEMS

  1. Consideration of update from IP Task Force and proposal to modify the payback requirement for products licensed by for-profit entities.
  2. Report from and possible consideration of study of proposal from the California State University system.
  3. Consideration of Standards Working Group items from 7/27/07 meeting including:
       a. Use of cell lines derived under Japanese Guidelines for Derivation and Utilization of Human Embryonic
            tem Cells;
       b. Limitations on payment for cells; and
       c. Requirements for use of somatic cells and human tissue
  4. Consideration of appointment of new scientific members of the Grants Review Working Group.
  5. Consideration of concept plan for RFA 07-03.
 

CLOSED SESSION

  1. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).
 

OPEN SESSION

  1. Public report of any action taken, if necessary, during closed session.
 

DISCUSSION ITEMS

  1. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

 

Transcripts: 

© 2013 California Institute for Regenerative Medicine